Targeted therapy for spinal cancer
Targeted therapies for spinal cancer work to target specific pathways or abnormalities in spinal tumor cells involved in tumor growth. We will likely combine targeted therapy with other spinal cancer treatments, such as chemotherapy. This treatment is often an option for spinal cancer patients who have a tumor recurrence after previous spinal cancer treatments.
One targeted therapy used for spinal tumors is bevacizumab (Avastin®), which is given intravenously. A monoclonal antibody, this spinal cancer treatment works to stop the formation of new blood vessels that a tumor needs to grow (a process known as angiogenesis).
Managing the side effects of spinal cancer targeted therapy
Targeted therapy can cause side effects, such as low blood counts, tiredness, mouth sores, nausea, diarrhea, high blood pressure and fluid buildup (usually in the legs).
Throughout your spinal cancer treatment, your care team provides various supportive care services, like nutrition therapy, naturopathic medicine, pain management and oncology rehabilitation to keep you strong, reduce side effects and improve your quality of your life.